Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568996 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
A Early Phase 1 study, sponsored by John Kirkwood.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 17
- Enrollment target
NCT01568996 is a Early Phase 1 study that has completed, run by John Kirkwood. The registered enrollment target is 17 participants.
The verdict
NCT01568996, a Early Phase 1 study, has completed, sponsored by John Kirkwood.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a pilot study to see if oral administration of freeze dried, powdered broccoli sprouts have any effect on whether moles end up becoming melanoma.
Interventions
- DRUG broccoli sprout extract - sulforaphane (BSE-SFN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568996
The ClinicalTrials.gov registry entry for NCT01568996 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John Kirkwood, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which broccoli sprout extract - sulforaphane (BSE-SFN) is the first listed.
NCT01568996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568996 about?
NCT01568996 is a clinical study titled "Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions". This is a pilot study to see if oral administration of freeze dried, powdered broccoli sprouts have any effect on whether moles end up becoming melanoma.
What is the current status of trial NCT01568996?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2012-08. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01568996?
The interventions under investigation include: broccoli sprout extract - sulforaphane (BSE-SFN) (DRUG).
Who is sponsoring clinical trial NCT01568996?
This trial is sponsored by John Kirkwood, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.